UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015773
Receipt number R000018347
Scientific Title A biomarker investigation for the recurrence and/or activity of recurrent glomerulonephritis in renal transplant recipients
Date of disclosure of the study information 2014/12/01
Last modified on 2023/10/06 11:59:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A biomarker investigation for the recurrence and/or activity of recurrent glomerulonephritis in renal transplant recipients

Acronym

A biomarker investigation for the recurrence and/or activity of recurrent glomerulonephritis in renal transplant recipients

Scientific Title

A biomarker investigation for the recurrence and/or activity of recurrent glomerulonephritis in renal transplant recipients

Scientific Title:Acronym

A biomarker investigation for the recurrence and/or activity of recurrent glomerulonephritis in renal transplant recipients

Region

Japan


Condition

Condition

kidney transplant recipients

Classification by specialty

Nephrology Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To establish the biomarkers for the detection of the recurrence and/or activity of recurrent glomerulonephritis in renal transplant recipients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Pathological diagnosis of post-transplant IgA deposition in the allograft and its activity (Oxford classification, pathological severity score of Japanese Society of Nephrology, and the existence/ absence of crescent formation)
: At the time of allograft biopsy

Key secondary outcomes

1) Serological IgA activity (galactose-deficient IgA1, galactose-deficient IgA1-specific IgA, galactose-deficient IgA1-specific IgG, and immune complex of galactose-deficient IgA1 and galactose-deficient IgA1-specific IgA/IgG)
2) Urinary WT1-positive cells and CD68-positive cells
3) Type of the original disease for end stage renal disease
4) Pathological expression of CD71 (IgA receptor) in the mesangial cells
5) Banff classification score, the existence of fibrous intimal thickening of interlobular artery, and glomerular sclerosis index
6) Urinary angiotensinogen
7) The type, dose, blood concentration and AUC of immunosuppressants
8) Allograft function (eGFRCr and eGFRCys)
9) Urinary protein excretion, urinary albumin excretion, urinary occult blood, urinary NAG and microscopic urinalysis
10) Blood pressure and the type and dose of antihypertensive drug(s)
11) Blood biochemical test
1~7: at the time of allograft biopsy
8~11: at the time of allograft biopsy, and 1 and 2 years after allograft biopsy


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Recipients who are scheduled allograft biopsy and agreed with the study

Key exclusion criteria

1) Patients without agreement
2) Patients who are under 16 years-old

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tadashi Sofue

Organization

Kagawa University Hospital

Division name

Department of Nephrology

Zip code


Address

1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan

TEL

087-891-2149

Email

sofue@med.kagawa-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tadashi Sofue

Organization

Kagawa University Hospital

Division name

Department of Nephrology

Zip code


Address

1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, Japan

TEL

087-891-2149

Homepage URL


Email

sofue@med.kagawa-u.ac.jp


Sponsor or person

Institute

Kagawa University, Faculty of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

香川大学医学部附属病院, 東京女子医科大学八千代医療センター


Other administrative information

Date of disclosure of the study information

2014 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2014 Year 11 Month 14 Day

Date of IRB

2010 Year 10 Month 14 Day

Anticipated trial start date

2014 Year 12 Month 01 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective cohort study
Predictive variable: biomarkers (serological IgA activity and urinary WT1-positive cells)
Outcome variable: pathological diagnosis of post-transplant IgA deposition in the allograft and its activity


Management information

Registered date

2014 Year 11 Month 28 Day

Last modified on

2023 Year 10 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018347


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name